Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × Tomography, Optical Coherence × Clear all

Status

Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Telangiectasis 1 Stomatitis 1 Rosacea 1 Port-Wine Stain 1 Neoplasms 1 Lung Neoplasms 1 Hemangioma 1 Head and Neck Neoplasms 1 Breast Neoplasms 1

Interventions

Gemcitabine 29 pembrolizumab 22 Cyclophosphamide 19 Paclitaxel 17 Irinotecan 17 Carboplatin 17 Fluorouracil 16 Docetaxel 16 Capecitabine 16 Leucovorin 13 Bevacizumab 12 fludarabine 11 Oxaliplatin 11 Everolimus 11 Pemetrexed 10 Erlotinib Hydrochloride 10 Dexamethasone 10 Rituximab 9 Cisplatin 9 Blood Specimen Collection 9 venetoclax 8 Cetuximab 8 Trastuzumab 7 Nivolumab 7 Sunitinib 6 Ipilimumab 6 Epoetin Alfa 6 Bortezomib 6 Azacitidine 6 trametinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01039311 2013-02-01

OCT

University of Oklahoma

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡